infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Services
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 7 of 187 articles from: Disease course and symptoms

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • UCLA study finds cholesterol regulator plays key role in development of liver scarring, cirrhosis

    Eurekalert Medicine & Health / 30 March 2011

  • The Hepatitis C Pipeline Report

    Treatment Action Group / 09 March 2011

  • OraSure Technologies Receives FDA Approval for Its OraQuick(R) HCV Rapid Test Using Fingerstick Whole Blood

    Stock Markets Review / 22 February 2011

  • Nanotechnology may lead to new treatment of liver cancer

    Eurekalert Medicine & Health / 22 February 2011

  • Vertex urges CDC to recommend hep C screening, to nudge `second tsunami` of patients

    EATG / 03 February 2011

  • New drugs take aim at hepatitis C, spur debate on whether to test baby boomers

    Canadian Press / 18 January 2011

  • Liver disease a possible predictor of stroke: Study

    Eurekalert Medicine & Health / 07 January 2011

← Prev1...1516171819Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
      • Transmission and prevention
      • Diagnosis and monitoring
      • Disease course and symptoms
      • HCV and coinfections
      • Living with HCV
      • Treatment issues
      • Side effects
      • Therapies
      • Liver transplants
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2021. All rights reserved. We are not responsible for the content of external websites.

We are grateful to Abbvie, Janssen, Merck and Gilead for funding infohep.org. Our funders have had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//   www.worldhepatitisalliance.org   www.elpa-info.org